Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00490503 · ClinicalTrials.gov registry record

Non-Invasive Magnetic Resonance Imaging (MRI) and Magnetic Resonance Spectroscopy Techniques (MRS) for Assessing Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer

A clinical trial, sponsored by M.D. Anderson Cancer Center.

Completed
Registry status
20
Enrollment target

NCT00490503: Completed study, sponsored by M.D. Anderson Cancer Center.

NCT00490503 is a clinical trial that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT00490503 has completed, sponsored by M.D. Anderson Cancer Center.

COMPLETED
Registry status
20 participants
Enrollment target

Study Summary

The goal of this clinical research study is to learn if magnetic resonance imaging (MRI) with magnetic resonance spectroscopy (MRS) can show the effects of pre-surgical chemotherapy in breast cancer patients who are eligible to receive preoperative chemotherapy.

Primary Outcome

Quantitative measures of tissue function obtained non-invasively by dynamic contrast enhanced (DCE) MRI, diffusion-weighted (DW) MRI, and proton MR spectroscopy (1H MRS) techniques to assess effects of pre-surgical chemotherapy in breast cancer patients eligible for preoperative chemotherapy.

Interventions

  • PROCEDURE Magnetic Resonance Imaging (MRI)
  • PROCEDURE Magnetic Resonance Spectroscopy (MRS)

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2006-10-25
Est. Completion 2022-10-18
M.D. Anderson Cancer Center

2,692 total trials

What the finished NCT00490503 record still lists

NCT00490503 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 20 participants, a relatively small participant target.

The record links to 0 conditions, and to 2 interventions - of which Magnetic Resonance Imaging (MRI) is the first listed.

NCT00490503 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00490503 about?

NCT00490503 is a clinical study titled "Non-Invasive Magnetic Resonance Imaging (MRI) and Magnetic Resonance Spectroscopy Techniques (MRS) for Assessing Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer". The goal of this clinical research study is to learn if magnetic resonance imaging (MRI) with magnetic resonance spectroscopy (MRS) can show the effects of pre-surgical chemotherapy in breast cancer patients who are eligible to receive preoperative chemotherapy.

What is the current status of trial NCT00490503?

This trial is currently completed. The enrollment target is 20 participants. The study started on 2006-10-25. Estimated completion is 2022-10-18.

What interventions are being tested in trial NCT00490503?

The interventions under investigation include: Magnetic Resonance Imaging (MRI) (PROCEDURE), Magnetic Resonance Spectroscopy (MRS) (PROCEDURE).

Who is sponsoring clinical trial NCT00490503?

This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.

Learn More About Clinical Trials

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00573339 · 20 participants

    Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing

  • NCT00692939 · 20 participants · Phase 1

    Autologous Stem Cell Transplantation for Crohn's Disease

  • NCT00967785 · 20 participants · Phase 1

    A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

  • NCT01406691 · 20 participants · Phase 4

    Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT00490503, the US trial registry maintained by the National Library of Medicine. NCT00490503 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.